Product Information
METHYLPHENIDATE 20 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.2102 per EA under NDC 75834032601. Its NADAC has been published 94 times since Nov 6, 2024.
FDA first approved this application on Feb 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834032601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208737FDA Approved
2/1/2019
TE Code
AB
On Market Since
4/16/2024
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 20 MG TABLET has been published 94 times since Nov 6, 2024, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2102 per EA |
|---|---|
| All-time high | $0.2347 (Nov 13, 2024) |
| All-time low | $0.1962 (Apr 22, 2026) |
| 52-week high | $0.2332 |
| 52-week low | $0.1962 |
| Median price | $0.2134 |
| Average price | $0.2160 |
| Largest weekly change | -14.9% (Nov 20, 2024) |
| Weeks tracked | 94 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 20 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.2102 per EA (NDC 75834032601), effective Aug 19, 2026.
How has the price of METHYLPHENIDATE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 20 MG TABLET has declined 10.5%. It has been tracked across 94 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 20 MG TABLET?
Since Nov 6, 2024, the NADAC for METHYLPHENIDATE 20 MG TABLET has ranged from a low of $0.1962 (Apr 22, 2026) to a high of $0.2347 (Nov 13, 2024), with a median of $0.2134 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 20 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 20 MG TABLET?
METHYLPHENIDATE 20 MG TABLET (NDC 75834032601) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.